Long-term effects of the treatment of polycythemia vera with recombinant interferon-αSILVER, Richard T.Cancer. 2006, Vol 107, Num 3, pp 451-458, issn 0008-543X, 8 p.Article

The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis : an alternative proposalSPIVAK, Jerry L; SILVER, Richard T.Blood. 2008, Vol 112, Num 2, pp 231-239, issn 0006-4971, 9 p.Article

Treatment of polycythemia veraSILVER, Richard T.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 4, pp 437-442, issn 0094-6176, 6 p.Article

Chronic myeloid leukemiaSILVER, Richard T.Hematology/oncology clinics of North America. 2003, Vol 17, Num 5, pp vi-vii, issn 0889-8588, 17 p.Article

Recombinant interferon-a may retard progression of early primary myelofibrosis: a preliminary reportSILVER, Richard T; VANDRIS, Katherine; GOLDMAN, Joshua J et al.Blood. 2011, Vol 117, Num 24, pp 6669-6672, issn 0006-4971, 4 p.Article

Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled TrialMESA, Ruben A; GOTLIB, Jason; HARVEY, Jimmie H et al.Journal of clinical oncology. 2013, Vol 31, Num 10, pp 1285-1292, issn 0732-183X, 8 p.Article

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for MyelofibrosisVERSTOVSEK, Srdan; MESA, Ruben A; TALPAZ, Moshe et al.The New England journal of medicine. 2012, Vol 366, Num 9, pp 799-807, issn 0028-4793, 9 p.Article

Characterization of murine JAK2^V617F-positive myeloproliferative diseaseBUMM, Thomas G. P; ELSEA, Collin; CORBIN, Amie S et al.Cancer research (Baltimore). 2006, Vol 66, Num 23, pp 11156-11165, issn 0008-5472, 10 p.Article

Correlation of three methods of measuring cytogenetic response in chronic myelocytic leukemiaLESSER, Martin L; DEWALD, Gordon W; SISON, Cristina P et al.Cancer genetics and cytogenetics. 2002, Vol 137, Num 2, pp 79-84, issn 0165-4608Article

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 studyTALPAZ, Moshe; SILVER, Richard T; HOCHHAUS, Andreas et al.Blood. 2002, Vol 99, Num 6, pp 1928-1937, issn 0006-4971Article

Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid LeukemiaSHAH, Neil P; KANTARJIAN, Hagop M; KHOROSHKO, Nina et al.Journal of clinical oncology. 2008, Vol 26, Num 19, pp 3204-3212, issn 0732-183X, 9 p.Article

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy. CommentaryROWE, Jacob M; HOCHHAUS, Andreas; NIEDERWIESER, Dietger et al.Blood. 2007, Vol 109, Num 6, issn 0006-4971, 2271,2303-2309 [8 p.]Article

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disordersJONES, Amy V; KREIL, Sebastian; WHITE, Helen et al.Blood. 2005, Vol 106, Num 6, pp 2162-2168, issn 0006-4971, 7 p.Article

A phase 2 study of imatinib in patients with relapsed or refractory philadelphia chromosome-positive acute lymphoid leukemiasOTTMANN, Oliver G; DRUKER, Brian J; BACCARANI, Michele et al.Blood. 2002, Vol 100, Num 6, pp 1965-1971, issn 0006-4971, 7 p.Article

In vivo two-photon excited fluorescence microscopy reveals cardiac- and respiration-dependent pulsatile blood flow in cortical blood vessels in miceSANTISAKULTARM, Thom P; CORNELIUS, Nathan R; NISHIMURA, Nozomi et al.American journal of physiology. Heart and circulatory physiology. 2012, Vol 71, Num 4, issn 0363-6135, H1367-H1377Article

TNFα facilitates clonal expansion of JAK2^V617F positive cells in myeloproliferative neoplasmsFLEISCHMAN, Angela G; AICHBERGER, Karl J; LORIAUX, Marc M et al.Blood. 2011, Vol 118, Num 24, pp 6392-6398, issn 0006-4971, 7 p.Article

Jumping translocations of the long arms of chromosome 1 in myeloid malignancies is associated with a high risk of transformation to acute myeloid leukaemiaNAJFELD, Vesna; TRIPODI, Joseph; SCALISE, Angela et al.British journal of haematology. 2010, Vol 151, Num 3, pp 288-291, issn 0007-1048, 4 p.Article

The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasmsJONES, Amy V; CAMPBELL, Peter J; SILVER, Richard T et al.Blood. 2010, Vol 115, Num 22, pp 4517-4523, issn 0006-4971, 7 p.Article

Four-Drug Combination Chemotherapy (Methotrexate, Cyclophosphamide, Hexamethylmelamine, and CCNU) for Non-Small Cell Bronchogenic Carcinoma : A Cancer and Leukemia Group B StudyGREEN, Mark; HORTON, Carol; SPAULDING, Monica et al.Journal of clinical oncology. 2008, Vol 26, Num 19, issn 0732-183X, c152-c158, 3112-3113 [9 p.]Article

Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alphaJONES, Amy V; SILVER, Richard T; REITER, Andreas et al.Blood. 2006, Vol 107, Num 8, pp 3339-3341, issn 0006-4971, 3 p.Article

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasmsJONES, Amy V; CHASE, Andrew; GRAND, Francis et al.Nature genetics. 2009, Vol 41, Num 4, pp 446-449, issn 1061-4036, 4 p.Article

Examination of platelet function in whole blood under dynamic flow conditions with the cone and plate(let) analyzer : Effect of erythrocytosis andthrombocytosisPEERSCHKE, Ellinor I; SILVER, Richard T; WEKSLER, Babette B et al.American journal of clinical pathology. 2007, Vol 127, Num 3, pp 422-428, issn 0002-9173, 7 p.Article

Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia veraZEYU XIONG; YAN YAN; ENLI LIU et al.Clinical immunology (Orlando, Fla. Print). 2007, Vol 122, Num 3, pp 279-287, issn 1521-6616, 9 p.Article

International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)TEFFERI, Ayalew; BAROSI, Giovanni; CORTES, Jorge et al.Blood. 2006, Vol 108, Num 5, pp 1497-1503, issn 0006-4971, 7 p.Article

Response criteria for myelofibrosis with myeloid metaplasia : results of an initiative of the European Myelofibrosis Network (EUMNET). CommentaryBAROSI, Giovanni; BORDESSOULE, Dominique; LE BOUSSE-KERDILES, Marie-Caroline et al.Blood. 2005, Vol 106, Num 8, pp 2598-2599, issn 0006-4971, 7 p.Article